Literature DB >> 20423300

Assessing structure, function and druggability of major inhibitory neurotransmitter gamma-aminobutyrate symporter subtypes.

J Kardos1, A Palló, A Bencsura, A Simon.   

Abstract

Ambient level of gamma -aminobutyric acid (GABA), the major inhibitory neurotransmitter of the brain is mediated by neuronal and glial GABA transporters (GATs), members of the sodium and chloride ion-dependent solute carrier family. The neuronal GABA transporter subtype (GAT-1) has already been proven to be the target for the antiepileptic drug Tiagabine. However, druggability of glial GAT-2 and GAT-3 is yet to be established. Recent advances in structure elucidation of a bacterial orthologue leucine transporter in complex with different substrates substantiate homology modeling of human GATs (hGATs). These modeling studies can provide mechanistic clues for structure-based prediction of the potential of medicinal chemistry campaigns. A recently identified characteristic structural feature of the occluded conformation of hGATs is that similar extra- and intracellular gates are formed by middle-broken transmembrane helices TM1 and TM6. Binding crevice formed by unwound segments of broken helices facilitates symport of GABA with Na+ ion via fitting of GABA to TM1-bound Na+ closely inside. Favored accommodation of substrate inhibitors with high docking score predicts efficient inhibition of the neuronal hGAT-1 if the TM1-TM8 binding prerequisite for GABA was used. Docking, molecular dynamics and transport data indicate, that amino acids participating in substrate binding of the neuronal hGAT-1 and the glial hGAT-2 and hGAT-3 subtypes are different. By contrast, substrate binding crevices of hGAT-2 and hGAT-3 cannot be distinguished, avoiding sensible prediction of efficient selective substrate inhibitors. Glial subtypes might be specifically distinguished by interfering Zn2+ binding in the second extracellular loop of hGAT-3. Formation of the unique ring-like Na+-GABA complex in the occluded binding crevices anticipates family member symporters exploring chemiosmotic energy via reversible chemical coupling of Na+ ion.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20423300     DOI: 10.2174/092986710791299939

Source DB:  PubMed          Journal:  Curr Med Chem        ISSN: 0929-8673            Impact factor:   4.530


  4 in total

1.  Inhibitory action of antidepressants on mouse Betaine/GABA transporter (BGT1) heterologously expressed in cell cultures.

Authors:  Chiharu Sogawa; Kazumi Ohyama; Takashi Masuko; Tadashi Kusama; Katsuya Morita; Norio Sogawa; Shigeo Kitayama
Journal:  Int J Mol Sci       Date:  2012-02-24       Impact factor: 6.208

2.  Sodium-assisted formation of binding and traverse conformations of the substrate in a neurotransmitter sodium symporter model.

Authors:  Ágnes Simon; Ákos Bencsura; László Héja; Csaba Magyar; Julianna Kardos
Journal:  Curr Drug Discov Technol       Date:  2014

3.  Dual Role for Astroglial Copper-Assisted Polyamine Metabolism during Intense Network Activity.

Authors:  Zsolt Szabó; Márton Péter; László Héja; Julianna Kardos
Journal:  Biomolecules       Date:  2021-04-19

4.  A binding mode hypothesis of tiagabine confirms liothyronine effect on γ-aminobutyric acid transporter 1 (GAT1).

Authors:  Andreas Jurik; Barbara Zdrazil; Marion Holy; Thomas Stockner; Harald H Sitte; Gerhard F Ecker
Journal:  J Med Chem       Date:  2015-02-26       Impact factor: 8.039

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.